Skip to main content
SIU School of Medicine Logo

Domain Menu

  • Patient Care
  • School of Medicine

Main Menu Edu Secondary

  • faculty
  • intranet
  • library
  • news & events
  • donate
  • careers
I am a...
  • Patient
  • Donor or Friend
  • Prospective Employee
  • Student/Prospective Student
  • Resident or Fellow
  • Alumni

Main Menu Edu

Main Menu Close
Main Menu
  • Degree Programs
  • Research
  • Academic & Clinical Departments
  • Centers & Institutes
  • Community Programs
    • Equity, Diversity and Inclusion
    • External Relations
    • Family and Community Medicine
    • Office of Community Care
    • Office of Correctional Medicine
    • Population Science and Policy
    • Rural Health and Social Service Development
  • About Us
    • Administrative offices
    • Careers
    • Why SIU School of Medicine
      • Strategic plan
      • A Model for Medical Education
      • Facts and figures
      • Our campuses
    • Economic Impact Report (pdf)
    • History
      • Notable alumni
      • Points of pride
      • Timeline
    • Leadership
      • SIU Medicine Board of Directors
      • SIU School of Medicine Leadership
    • News and Events
Search Site close Close

Breadcrumb

  1. Home
  2. Search

Search Results

search
Reset

Filter Results

By Type

  • (-) Profiles (1260)
  • (-) Trial (47)
  • Departments (98)
  • Events (199)
  • General Results (2208)
  • Lab (5)
  • Locations (71)
  • Medical Services (13)
  • News (1332)
Reset

Filter Results

By Type

  • (-) Profiles (1260)
  • (-) Trial (47)
  • Departments (98)
  • Events (199)
  • General Results (2208)
  • Lab (5)
  • Locations (71)
  • Medical Services (13)
  • News (1332)
Showing: 1307 Results
search
Profiles
Kinan Abou-Kassem

Kinan Abou-Kassem, MD

Diagnostic Radiology Residency
Trial
Simmons Cancer Institute

KO-MEN-008: Phase 1 Study to Determine the Safety and Tolerability of Ziftomenib Combinations for the Treatment of KMT2A-rearranged or NPM1-mutant Relapsed/Refractory Acute Myeloid Leukemia

Active recruiting

Examining the safety, tolerability, and effectiveness of investigational drug ziftomenib in combination with standard of care treatments for patients with relapsed/refractory acute myeloid leukemia. The study drug will be examined with the following agents: FLAG-IDA, low-dose cytarabine, and gilteritinib.

Contact: Kathy Robinson phone217-545-1946 emailsciresearchbc@siumed.edu
Profiles
Kody Bolk

Kody Bolk, MD

Assistant Professor
(ENT) Otolaryngology- Head and Neck Surgery
Profiles
Kortni Kemper

Kortni Kemper, MD

Internal Medicine
Profiles
Krishna Rao

Krishna Rao, MD

Associate Professor, Hematology/Oncology, Department of Internal Medicine
Internal Medicine
Profiles
Krishna Taneja

Krishna Taneja, MD

Psychiatry
Profiles
Krista Bonney

Krista Bonney, MD

General Surgery
General Results
Kristan Eaton

Kristan Eaton

Executive Director of Human Resources
Human Resources
Profiles
Kristen Cecil

Kristen Cecil

Obstetrics and Gynecology
Profiles
Kristen Leadbetter

Kristen Leadbetter, MD

Assistant Professor of Clinical Pediatrics - Neonatology, Co-Director Undergraduate Medical Education Program
Pediatrics
Go back to search filters

Pagination

  • Previous page ‹‹
  • …
  • Page 67
  • Page 68
  • Page 69
  • Page 70
  • Current page 71
  • Page 72
  • Page 73
  • Page 74
  • Page 75
  • …
  • Next page ››

This browser is no longer supported and some key features will not work. We strongly recommend using Edge, Chrome 70+, Safari 5.x+ and Firefox 5.x+.

SIU School of Medicine Logo
© 2025 SIU Board of Trustees all rights reserved

Legal

  • Equal Opportunity Employer
  • Nondiscrimination Statement
  • Privacy Policy
  • FOIA
  • ADA

About Us

  • About Us
  • Contact
  • SIU Intranet
  • SIU Medicine
  • Southern Illinois University Carbondale
  • Southern Illinois University Edwardsville
  • Southern Illinois University System

Social

  • Facebook
  • Twitter
  • Youtube
  • Instagram